These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24051034)

  • 1. The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules.
    Paredes-Juarez GA; de Haan BJ; Faas MM; de Vos P
    J Control Release; 2013 Dec; 172(3):983-92. PubMed ID: 24051034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules.
    de Vos P; Spasojevic M; de Haan BJ; Faas MM
    Biomaterials; 2012 Aug; 33(22):5552-9. PubMed ID: 22560199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of inflammatory reaction in the use of purified alginate microcapsules.
    Kim AR; Hwang JH; Kim HM; Kim HN; Song JE; Yang YI; Yoon KH; Lee D; Khang G
    J Biomater Sci Polym Ed; 2013; 24(9):1084-98. PubMed ID: 23683040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid.
    de Haan BJ; Rossi A; Faas MM; Smelt MJ; Sonvico F; Colombo P; de Vos P
    J Biomed Mater Res A; 2011 Sep; 98(3):394-403. PubMed ID: 21630432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.
    Strand BL; Ryan TL; In't Veld P; Kulseng B; Rokstad AM; Skjak-Brek G; Espevik T
    Cell Transplant; 2001; 10(3):263-75. PubMed ID: 11437072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression.
    Jayant RD; McShane MJ; Srivastava R
    Int J Pharm; 2011 Jan; 403(1-2):268-75. PubMed ID: 21050881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Technology Platform to Test the Efficacy of Purification of Alginate.
    Paredes-Juarez GA; de Haan BJ; Faas MM; de Vos P
    Materials (Basel); 2014 Mar; 7(3):2087-2103. PubMed ID: 28788557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition.
    Ponce S; Orive G; Hernández R; Gascón AR; Pedraz JL; de Haan BJ; Faas MM; Mathieu HJ; de Vos P
    Biomaterials; 2006 Oct; 27(28):4831-9. PubMed ID: 16766026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules.
    Robitaille R; Dusseault J; Henley N; Desbiens K; Labrecque N; Hallé JP
    Biomaterials; 2005 Jul; 26(19):4119-27. PubMed ID: 15664639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in binding diblock copolymers on hydrophilic alginate beads for providing an immunoprotective membrane.
    Spasojevic M; Bhujbal S; Paredes G; de Haan BJ; Schouten AJ; de Vos P
    J Biomed Mater Res A; 2014 Jun; 102(6):1887-96. PubMed ID: 23853069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
    Haque T; Chen H; Ouyang W; Martoni C; Lawuyi B; Urbanska AM; Prakash S
    Mol Pharm; 2005; 2(1):29-36. PubMed ID: 15804175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules.
    De Vos P; De Haan B; Van Schilfgaarde R
    Biomaterials; 1997 Feb; 18(3):273-8. PubMed ID: 9031730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
    Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
    J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
    Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
    Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy.
    Strand BL; Mørch YA; Espevik T; Skjåk-Braek G
    Biotechnol Bioeng; 2003 May; 82(4):386-94. PubMed ID: 12632394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein contaminants in the immunogenicity of alginates.
    Ménard M; Dusseault J; Langlois G; Baille WE; Tam SK; Yahia L; Zhu XX; Hallé JP
    J Biomed Mater Res B Appl Biomater; 2010 May; 93(2):333-40. PubMed ID: 20225212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of cells in alginate gels.
    Sánchez P; Hernández RM; Pedraz JL; Orive G
    Methods Mol Biol; 2013; 1051():313-25. PubMed ID: 23934814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of poly-L-lysine coating on macrophage activation by alginate-based microcapsules: assessment using a new in vitro method.
    Juste S; Lessard M; Henley N; Ménard M; Hallé JP
    J Biomed Mater Res A; 2005 Mar; 72(4):389-98. PubMed ID: 15669081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions.
    van Hoogmoed CG; Busscher HJ; de Vos P
    J Biomed Mater Res A; 2003 Oct; 67(1):172-8. PubMed ID: 14517874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating.
    King A; Strand B; Rokstad AM; Kulseng B; Andersson A; Skjåk-Braek G; Sandler S
    J Biomed Mater Res A; 2003 Mar; 64(3):533-9. PubMed ID: 12579568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.